Market Access
Managed Markets: Why Access Is No Longer Just About “Tier”
SURE, FORMULARY TIERS ARE IMPORTANT. But they are only part of the equation. By ...
PM360 Q & A with Joe Daley, President of GSW
Earlier this year, inVentiv Health combined two of their healthcare communications agencies, GSW and ...
How the Affordable Care Act Changes the Patient Journey (Part Three)
Non-Adherence, Technology and DTC A recent study from Capgemini Consulting found that the pharma ...
Developing a Data Acquisition Strategy for Your Specialty Brand
Information collection for tracking specialty product distribution in the U.S. has become highly fragmented, ...
Return on Reputation: How A Better Rep Can Lead to More Success
Earlier this month, APCO Worldwide released its findings from its third annual State of ...
How the Affordable Care Act Changes the Patient Journey (Part Two)
Evidence-Based Medicine Along with creating an increase in healthcare demand and the subsequent provider ...
Six Factors You Shouldn’t Ignore When Marketing Your Brand to Payers
No matter how strong the portfolio, every pharmaceutical company has at least one product ...
A Pharma Marketer’s Guide to Multivariate Analyses
Putt’s Law states, “Technology is dominated by two types of people: Those who understand ...
When It Comes to Licensing Deals, It’s All About Market Access
Reduced internal R&D productivity, patent expirations and stagnant global economic growth have caused pharma ...
- 2013
- Digital Tactics
- Feature Articles
- Industry News
- Issues
- July
- Market Access
- Slideshow
- Social Media
- Uncategorized
Decision-Makers and a Dynamic Marketplace: Who and What Are Leading Today’s Marketing Power Shift?
The quest to understand drivers of product uptake and use is as old as ...
The Bellwethers of Brand Performance
As is often the case, it’s not a single driver that shapes a trend ...
